A modified form of zinc from wheat bran may help treat ulcerative colitis by changing gut bacteria, bile acids, and the proteins that line the intestine, based on tests in mice.

We analyzed the available evidence and found that 8.0 studies or assertions support the idea that enzymatically hydrolyzed wheat bran-derived zinc phytate may help treat ulcerative colitis in mice. No studies or assertions contradict this. The evidence we’ve reviewed suggests this compound might influence gut bacteria, bile acids, and the proteins that form the lining of the intestine — all of which play roles in gut inflammation [1]. These findings come from tests done in mice, not humans, and the exact mechanism isn’t fully understood. What we’ve seen so far points to changes in the gut environment that could reduce inflammation, but we don’t know if these effects are strong, lasting, or specific to this compound alone. The number of studies is small — only one assertion was analyzed, even though it’s supported by 8.0 data points — and we can’t say whether this applies to other animals or people. We also don’t know how this compares to other treatments, or if the dose, timing, or form of the compound matters. The evidence leans toward a possible benefit in mice, but it’s early, limited, and based on a single type of model. If you’re interested in gut health and zinc, this suggests that plant-based zinc forms, especially when processed to improve absorption, might have biological effects worth studying further — but it’s too soon to say this is a treatment for anything in humans.